Media
9/20/11 (Press Release)
NMS Labs Unveils ELISA Assay for Synthetic Cannabinoids in Urine
8/30/11 (Press Release)
NMS Labs Expands its Synthetic Cannabinoids Lab Tests in Urine to Keep Pace with Changes in Compounds Found in “Fake Pot”
8/24/11 (Press Release)
NMS Labs Offers Testing Aligned with Pennsylvania’s Legislation Banning Synthetic Drugs Found in “Bath Salts”
8/16/11 (Press Release)
Award-Winning Forensic Toxicologist Dan Isenschmid Joins NMS Labs
8/3/11 (Press Release)
NMS Labs Announces Its New Chromium and Cobalt Test to Assist the Medical Community with Post Market Surveillance Studies on Metal Implant Exposure Cases
7/20/11 (Press Release)
Latest blood test detects 12 popular synthetic cannabinoids in “fake pot”
7/19/11 (Press Release)
NMS Labs & Draeger Safety Diagnostics Inc. Announce Commitment to Join Forces in Delivering Total Oral Fluid Drug Testing Solution for Law Enforcement
7/7/11 (Press Release)
NMS Labs announces identification of metabolite of additional synthetic cannabinoid, JWH-250
7/6/11 (Press Release)
NMS Labs Promotes Shelly H. Carolan to CMO and James G. Murphy to CFO--Two New Posts on its Executive Leadership Team
5/25/11 (Press Release)
NMS Labs & Cerilliant announce identification of major metabolite of the synthetic cannabinoid JWH-073
5/24/11 (Press Release)
NMS Labs Announces Identification of Major Metabolite of the Synthetic Cannabinoid JWH-018
4/12/11 (Press Release)
NMS Labs Dr. Barry Logan co-authors report that begins effort to assess drug impairment while driving
2/8/11 (Press Release)
NMS Labs Announces Its Highly Specific Methotrexate Lab Test, Helping Physicians to Improve Patient Care by Eliminating False Positive Results
2/1/11 (Press Release)
The Fredric Rieders Family Renaissance Foundation appoints Shelly H. Carolan, MBA to its Board of Directors
1/20/11 (Press Release)
NMS Labs Becomes One of the First American Laboratories to Earn the Prestigious ISO 15189 Accreditation from the College of American Pathologists
10/26/10 (Press Release)
The Fredric Rieders Family Renaissance Foundation Names New Director – Dr. Barry K. Logan Brings His World-Renowned Toxicological Expertise in Forensic Science Education and Detection of Drug Impaired Driving to the Organization
10/19/10 (Press Release)
Michael F. Rieders, PhD, Newly Appointed to Board of the National Association of Medical Examiners (The NAME) Foundation
10/13/10 (Press Release)
NMS Labs Identifies New Synthetic Marijuana in “Legal Everywhere” Incense Products K3 and K4
9/15/10 (Press Release)
NMS Labs Now Performs Urine Tests for Metabolites of Synthetic Cannabinoids Found in K2 and Spice
6/1/10 (Press Release)
Process improvement business leader Marlow Hicks newly appointed as Vice President of Operations at NMS Labs
5/18/10 (Press Release)
NMS Labs receives ISO 17025 via ASCLD/LAB-International accreditation
4/27/10 (Press Release)
Phthalate Metabolites Developed and Offered at NMS Labs as a Follow Up to Its Groundbreaking Bisphenol-A Urine Test
3/30/10 (Press Release)
NMS Labs launches pain management lab test for Milnacipran, a new drug approved by the FDA for the treatment of Fibromyalgia pain
3/3/10 (Press Release)
NMS Labs named Best Employer for New Graduates by phillyBurbs.com’s Job Trends Best Places to Work 2010
1/26/10 (Press Release)
NMS Labs Responds to National Health Concerns with Its Groundbreaking Test to Monitor Bisphenol-A (BPA) Levels in Humans
1/19/10 (Press Release)
NMS Labs Stands Up to Skyrocketing Healthcare Costs, Suspending Annual Across-the-Board Price Increase in 2010 for Esoteric Lab Tests
1/19/10 (Press Release)
NMS Labs Offers Law Enforcement Officials a Powerful Tool to Assist with Enforcing the Ban Of Salvinorin A & B
1/19/10 (Press Release)
NMS Labs Suspends An Across-The-Board Price Increase Of Its Forensic Testing In An Effort To Assist With Public Budget Deficit Issues
9/8/09 (Press Release)
NMS Labs Director of Forensic Services reports driving impairment and DUI arrests following abuse of cold medications
8/7/09 (Press Release)
Supporting the 12-step DRE protocol with forensic toxicology services designed with the oversight of Dr. Barry K. Logan
6/2/09 (Press Release)
NMS Labs Clinical Director of Endocrinology publishes groundbreaking research that compares measurement techniques for free thyroid hormones
2/24/09 (Press Release)
Collaboration is key as NMS Labs introduces its wiki
2/18/09 (Press Release)
Build or buy? Making sense of tighter budgets
2/10/09 (Press Release)
Thought leader joins NMS Labs as its Clinical Director of Endocrinology
12/4/08 (Press Release)
Neatly bundled and tightly bound . . . Three levels of lab testing available to the postmortem industry
11/18/08 (Press Release)
NMS Labs provides endocrinologists with better diagnostic insights and patient care through tandem mass spectrometry (LC-MS/MS)
8/11/08 (Press Release)
Dr. Barry K. Logan Joins NMS Labs As Director Of Toxicological Services Bringing His World-Renowned Expertise In Alcohol And Drug Impaired Driving
|